Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK Will Cut Sales Force And Reinvest In R&D If Pfizer Acts First

This article was originally published in The Pink Sheet Daily

Executive Summary

Company would “welcome” a decision by Pfizer to cut back its sales force, CEO Garnier declares. Analyst reports have ignited market speculation that Pfizer is ready to retool its sales and marketing infrastructure.

You may also be interested in...



Pfizer Unveils Sales Force Plan: Reorganization Involves “Modest” Cuts

The plan will be “very disappointing to our competitors,” CEO McKinnell declares. Pfizer will restructure sales force to reduce number of reps calling on individual doctors, but will not use layoffs to cut headcount significantly.

Pfizer Unveils Sales Force Plan: Reorganization Involves “Modest” Cuts

The plan will be “very disappointing to our competitors,” CEO McKinnell declares. Pfizer will restructure sales force to reduce number of reps calling on individual doctors, but will not use layoffs to cut headcount significantly.

Novartis Will Stand Tough On Sales Force Size, CEO Costa Says

Potential cuts to competitors' sales forces will give Novartis an opportunity to "leverage that asset," the exec says. Novartis' sales force continues to offer a strong return on investment, he notes.

Related Content

Topics

UsernamePublicRestriction

Register

OM006764

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel